ADC Therapeutics SA annual return on equity
2019
2020
2021
2022
ADC Therapeutics SA Return on Equity (ROE) Growth & History (ADCT)
ADC Therapeutics SA's return on equity was −122.28% for fiscal 2022.
View full ADC Therapeutics SA company overviewADC Therapeutics SA annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2022 | 2022-12-31 | −122.28% | −30.57 pp |
| 2021 | 2021-12-31 | −91.72% | +18.56 pp |
| 2020 | 2020-12-31 | −110.28% | −12.15 pp |
| 2019 | 2019-12-31 | −98.13% | — |
ADC Therapeutics SA quarterly return on equity
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2023 | 2023-06-30 | −323.87% | −277.56 pp |
| Q1 2023 | 2023-03-31 | −94.02% | −83.88 pp |
| Q4 2022 | 2022-12-31 | −24.97% | −5.51 pp |
| Q3 2022 | 2022-09-30 | −45.98% | −12.80 pp |
| Q2 2022 | 2022-06-30 | −46.31% | −19.53 pp |
| Q1 2022 | 2022-03-31 | −10.14% | +6.13 pp |
| Q4 2021 | 2021-12-31 | −19.46% | +5.59 pp |
| Q3 2021 | 2021-09-30 | −33.18% | — |
| Q2 2021 | 2021-06-30 | −26.78% | — |
| Q1 2021 | 2021-03-31 | −16.27% | — |
| Q4 2020 | 2020-12-31 | −25.04% | — |
ADC Therapeutics SA return on equity trends
Between the periods ended 2019-12-31 and 2022-12-31, ADC Therapeutics SA's return on equity decreased from −98.13% to −122.28%, a change of −24.15 percentage points. The latest reported quarter, Q2 2023, shows −323.87%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review ADC Therapeutics SA source filings ↗